|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US7879544B2
(en)
|
2002-07-29 |
2011-02-01 |
Hmgene Inc. |
Methods of identifying adipocyte specific genes, the genes identified, and their uses
|
|
US20080214437A1
(en)
|
2002-09-06 |
2008-09-04 |
Mohapatra Shyam S |
Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases
|
|
US20040101920A1
(en)
|
2002-11-01 |
2004-05-27 |
Czeslaw Radziejewski |
Modification assisted profiling (MAP) methodology
|
|
EP1740946B1
(en)
|
2004-04-20 |
2013-11-06 |
Genmab A/S |
Human monoclonal antibodies against cd20
|
|
US8257740B1
(en)
|
2011-08-15 |
2012-09-04 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles
|
|
US8246995B2
(en)
|
2005-05-10 |
2012-08-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells
|
|
ATE537190T1
(de)
|
2006-06-02 |
2011-12-15 |
Regeneron Pharma |
Hochaffine antikörper gegen den humanen il-6- rezeptor
|
|
GB0624500D0
(en)
*
|
2006-12-07 |
2007-01-17 |
Istituto Superiore Di Sanito |
A novel passive vaccine for candida infections
|
|
US20100310561A1
(en)
|
2007-06-06 |
2010-12-09 |
Boehringer Ingelheim International Gmbh |
Natriuretic fusion proteins
|
|
EP2370098A4
(en)
|
2008-12-03 |
2013-07-17 |
Morphosys Ag |
Antibodies for guanylyl cyclase receptors
|
|
TWI507525B
(zh)
|
2009-06-26 |
2015-11-11 |
Regeneron Pharma |
具天然免疫球蛋白形式之易分離的雙專一性抗體
|
|
SG183149A1
(en)
|
2010-02-08 |
2012-09-27 |
Regeneron Pharma |
Common light chain mouse
|
|
US10184942B2
(en)
|
2011-03-17 |
2019-01-22 |
University Of South Florida |
Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer
|
|
US9451770B2
(en)
|
2012-06-08 |
2016-09-27 |
Charles Despres |
Method of activating immune response in plants
|
|
SI3495387T1
(sl)
*
|
2012-07-13 |
2021-12-31 |
Roche Glycart Ag |
Bispecifična protitelesa proti VEGF/proti ANG-2 in njihova uporaba pri zdravljenju bolezni očesnih žil
|
|
TWI682941B
(zh)
|
2013-02-01 |
2020-01-21 |
美商再生元醫藥公司 |
含嵌合恆定區之抗體
|
|
US9914770B2
(en)
*
|
2013-04-30 |
2018-03-13 |
Intas Pharmaceuticals Ltd |
Cloning, expression and purification method for the preparation of ranibizumab
|
|
AR097306A1
(es)
|
2013-08-20 |
2016-03-02 |
Merck Sharp & Dohme |
Modulación de la inmunidad tumoral
|
|
CA2874083C
(en)
*
|
2014-12-05 |
2024-01-02 |
Universite Laval |
Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
|
|
WO2016131943A1
(en)
|
2015-02-20 |
2016-08-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of obesity and complications arising therefrom including type 2 diabetes
|
|
WO2017209553A2
(ko)
|
2016-06-03 |
2017-12-07 |
사회복지법인 삼성생명공익재단 |
환자 유래 세포를 이용한 항체 스크리닝 방법
|
|
WO2018075792A1
(en)
|
2016-10-20 |
2018-04-26 |
Regeneron Pharmaceuticals, Inc. |
Methods of lowering blood glucose levels
|
|
EP3630839A1
(en)
*
|
2017-06-01 |
2020-04-08 |
Xencor, Inc. |
Bispecific antibodies that bind cd 123 cd3
|
|
US20190135804A1
(en)
|
2017-11-03 |
2019-05-09 |
The United States Of America,As Represented By The Secretary,Department Of Health And Human Services |
Compositions and methods for the inhibition of pruritus
|
|
CA3115102A1
(en)
|
2018-10-23 |
2020-04-30 |
Regeneron Pharmaceuticals, Inc. |
Anti-npr1 antibodies and uses thereof
|
|
US12703762B2
(en)
*
|
2018-12-18 |
2026-08-11 |
Novartis Ag |
Reversal binding agents for anti-factor XI/XIa antibodies and uses thereof
|
|
PH12021553101A1
(en)
*
|
2019-06-12 |
2023-10-02 |
Novartis Ag |
Natriuretic peptide receptor 1 antibodies and methods of use
|
|
EP4259661A1
(en)
|
2020-12-14 |
2023-10-18 |
Novartis AG |
Reversal binding agents for anti-natriuretic peptide receptor 1 (npr1) antibodies and uses thereof
|
|
US12325752B2
(en)
|
2020-12-18 |
2025-06-10 |
Regeneron Pharmaceuticals, Inc. |
Immunoglobulin proteins that bind to NPR1 agonists
|
|
WO2023107957A1
(en)
|
2021-12-06 |
2023-06-15 |
Regeneron Pharmaceuticals, Inc. |
Antagonist anti-npr1 antibodies and methods of use thereof
|